Abstract P3005: Cannabinoid Receptor 1 Antagonist Genistein Attenuates Marijuana-Induced Vascular Inflammation
Mark Chandy,Tzu-tang T Wei,Masataka Nishiga,Angela Zhang,Kaavya K Kumar,Dilip Thomas,Amit Manhas,Siyeon Rhee,Johanne M Justesen,Ian Y Chen,Hung-Ta Wo,Johnson Y Yang,Saereh Khanamiri,Frederick Seidl,Noah Burns,Chun Liu,Nazish Sayed,Jiun-Jie Shie,Chih Fan Yeh,Kai-chien YANG,Edward Lau,Kara Lynch,Manuel Rivas,Brian Kobilka,Joseph C Wu
DOI: https://doi.org/10.1161/res.131.suppl_1.p3005
IF: 23.213
2022-08-05
Circulation Research
Abstract:Epidemiological studies reveal that marijuana increases the risk of cardiovascular disease (CVD); however, little is known about the mechanism. Δ 9 -tetrahydrocannabinol (Δ 9 -THC), the psychoactive component of marijuana, binds cannabinoid receptor 1 (CB1/CNR1) in the vasculature and is implicated in CVD. A UK Biobank analysis found that cannabis is an independent risk factor for CVD. We found that marijuana smoking activated inflammatory cytokines implicated in CVD. In silico virtual screening identified genistein, a soybean isoflavone, as a putative CB1 antagonist. Human-induced pluripotent stem cell-derived endothelial cells (hiPSC-ECs) were used to model Δ 9 -THC induced inflammation and oxidative stress via NF-κB signaling. Knockdown of the CB1 receptor with siRNA, CRISPR interference (CRISPRi), and genistein attenuate the effects of Δ 9 -THC. In mice, genistein blocked Δ 9 -THC-induced endothelial dysfunction in wire myograph, reduced atherosclerotic plaque, and had minimal penetration of the central nervous system (CNS). Genistein is a peripherally restricted CB1 antagonist that attenuates Δ 9 -THC-induced atherosclerosis.
cardiac & cardiovascular systems,peripheral vascular disease,hematology